Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:220
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [21] Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma
    Loomba, Rohit
    Liu, Jessica
    Yang, Hwai-I.
    Lee, Mei-Hsuan
    Lu, Sheng-Nan
    Wang, Li-Yu
    Iloeje, Uchenna H.
    You, San-Lin
    Brenner, David
    Chen, Chien-Jen
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (12) : 1636 - U305
  • [22] The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
    Tan, Yifei
    Zhang, Xiaoyun
    Zhang, Wei
    Tang, Li
    Yang, Hanwei
    Yan, Ke
    Jiang, Li
    Yang, Jian
    Li, Chuan
    Yang, Jiayin
    Wen, Tianfu
    Tang, Huairong
    Yan, Lunan
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (12) : 2038 - 2046
  • [23] Detection and Quantification of Hepatitis B Virus Genomes in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Virus Infection, Cirrhosis, and Hepatocellular Carcinoma Patients
    Poortahmasebi, Vahdat
    Alavian, Seyed Moayed
    Ghaziasadi, Azam
    Azadi, Arezou
    Toosi, Mohsen Nasiri
    Jazayeri, Seyed Mohammad
    HEPATITIS MONTHLY, 2021, 21 (10)
  • [24] Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
    Reddy, Arvind
    May, Elizabeth
    Ehrinpreis, Murray
    Mutchnick, Milton
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (48) : 9328 - 9333
  • [25] Risk scores for hepatocellular carcinoma in chronic hepatitis B
    Sherman, Morris
    Kim, Ray W.
    Dziura, James
    HEPATOLOGY, 2015, 61 (06) : 1784 - 1786
  • [26] Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Miyake, Yasuhiro
    Kobashi, Haruhiko
    Yamamoto, Kazuhide
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (05) : 470 - 475
  • [27] Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, Seung Up
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Song, Kijun
    Han, Kwang-Hyub
    MEDICINE, 2016, 95 (20)
  • [28] Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
    Tsai, JF
    Jeng, JE
    Ho, MS
    Chang, WY
    Hsieh, MY
    Lin, ZY
    Tsai, JH
    BRITISH JOURNAL OF CANCER, 1997, 76 (07) : 968 - 974
  • [29] Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection
    Mittal, Sahil
    Kramer, Jennifer R.
    Omino, Ronald
    Chayanupatkul, Maneerat
    Richardson, Peter A.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (02) : 252 - 259
  • [30] Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives
    Chen, PJ
    Chen, DS
    SEMINARS IN LIVER DISEASE, 1999, 19 (03) : 253 - 262